- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/13 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Patent holdings for IPC class C07D 295/13
Total number of patents in this class: 578
10-year publication summary
|
42
|
33
|
38
|
32
|
32
|
45
|
44
|
40
|
67
|
37
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acuitas Therapeutics Inc. | 139 |
22 |
| Massachusetts Institute of Technology | 10273 |
13 |
| The Trustees of the University of Pennsylvania | 4426 |
12 |
| The Regents of the University of California | 20802 |
11 |
| Beam Therapeutics Inc. | 292 |
11 |
| Dow Global Technologies LLC | 10981 |
8 |
| Modernatx, Inc. | 1279 |
7 |
| South China University of Technology | 1911 |
7 |
| Recurium IP Holdings, LLC | 123 |
7 |
| Centre National de La Recherche Scientifique | 11055 |
6 |
| The Salk Institute for Biological Studies | 448 |
6 |
| Albert Einstein College of Medicine, Inc. | 598 |
5 |
| Pharmatrophix, Inc. | 25 |
5 |
| PTC Therapeutics, Inc. | 473 |
5 |
| University College Cardiff Consultants Limited | 251 |
5 |
| The Procter & Gamble Company | 21853 |
4 |
| BASF SE | 21310 |
4 |
| Allergan, Inc. | 2159 |
4 |
| The Trustees of Columbia University in the City of New York | 3644 |
4 |
| Abbvie Inc. | 1822 |
4 |
| Other owners | 428 |